Ascorbic acid and dehydroascorbic acid were estimated in the blood of normal healthy subjects and diabetic patients. In normal subjects, blood contained only ascorbic acid while dehydroascorbic acid was practically absent. The ascorbic acid level was low in the blood of diabetic patients but the dehydroascorbic acid content was remarkably high, irrespective of age, sex, history of diabetes, or treatment. About 75 %of blood dehydroascorbic acid was present in the erythrocytes: the rest was in plasma. High blood dehydroascorbic acid levels were also found in 90 % of the non-diabetic offspring with both parents diabetic, in 24 % of the non-diabetic offspring with one parent diabetic, and in 75 % of the non-diabetic siblings of diabetic patients. It appears that, in persons having an hereditary predisposition to diabetes, high blood dehydroascorbic acid levels may be used as a marker for early detection of the disease.
Dehydroascorbic acid, a metabolite of ascorbic acid, is diabetogenic.' 2 Administration of dehydroascorbic acid to rats resulted in degranulation of the~-cells of the islets of Langerhans accompanied by hyperglycaemia," 4 It has been reported that feeding large doses of ascorbic acid also produced hyperglycaemia in guinea-pigs kept on a low-protein diet and that the hyperglycaemia was preceded by accumulation of dehydroascorbic acid in the blood," 7 There may be an interrelationship between high blood dehydroascorbic acid content and diabetes mellitus in human subjects." In a previous paper it has been briefly reported that persistently high levels of dehydroascorbic acid occur in the blood of diabetic patients but not in the blood of normal human subjects." However, it was not shown in that study if age, family history, duration ofthe disease, or treatment have any influence on blood dehydroascorbic acid levels, or whether persons with hereditary predisposition to diabetes also have elevated levels. It was considered worthwhile to undertake an extensive investigation in order better to understand the relationship between high blood dehydroascorbic acid content and diabetes mellitus. Therefore, blood dehydroascorbic acid levels in male and female diabetic patients of different age groups with varied status of the disease, as well as of their offspring and • Formerly, Indian Institute of Experimental Medicine, Calcutta 700 032, India. siblings, were estimated. The results are presented in this communication.
Patients and methods
Confirmed diabetic patients, of both maturity onset and juvenile types, were chosen from different diabetic clinics in Calcutta. They were diagnosed on the basis of 2-hour postprandial blood glucose levels (8 .9-18 mmol/l) and other clinical parameters. Patients having any other complication or co-existing disease of another system, eg, liver or kidneys, were not chosen. Some of the patients had definite family history of the disease while in a few cases no definite family history could be obtained. Some cases were of long duration while a few patients were newly diagnosed. Whenever any patient had any treatment it is indicated in the legends of the tables concerned. None of the patients was receiving vitamin C or any other drug therapy. They were taking a diet with restricted carbohydrate and high protein.
The group of normal subjects had 2-hour postprandial blood glucose levels of 2·8-5·0 mmol/I. They had no family history of diabetes. They did not have any history of organic disease and were not receiving vitamin C therapy.
Venous blood (5 m1) was collected in a vial containing heparin (approximately 50 units) 2 hours after a meal. The blood was analysed within 1 to 2 hours after collection. 65
Estimations of ascorbic acid and dehydroascorbic acid in blood, plasma, and erythrocytes were done as described previously." For the estimation of ascorbic acid in blood, carbon monoxide, generated by dropping formic acid over concentrated H 2S04 under a hood at room temperature, was slowly bubbled through 2 ml blood in a boiling tube for 3 minutes; 2 ml of 20% freshly prepared metaphosphoric acid solution was added and stirred, carbon monoxide was passed for a further 2 minutes and the mixture was centrifuged. The supernatant was filtered, and ascorbic acid was estimated in the filtrate by titration with a standard solution of 2,6-dichlorophenol indophenol (equivalent to 1-21lg of ascorbic acid/0·2-Q·4 ml of dye). Dehydroascorbic acid was estimated by substracting ascorbic acid from total ascorbic acid in blood. Total ascorbic acid was estimated in the filtrate obtained from the metaphosphoric acid extract of carbon monoxidesaturated blood by the 2,4-dinitrophenyl hydrazine method of Bessey et a [.9 Carbon monoxide was passed through blood to prevent spontaneous oxidation of ascorbic acid to dehydroascorbic acid, which takes place instantaneously when metaphosphoric acid is added to blood in the absence of carbon monoxide." Using this method, 98-100% recovery of ascorbic acid and dehydroascorbic acid was obtained when added (10-20 Ilg/ml) to normal or diabetic blood. The ascorbic acid and dehydroascorbic acid of normal or diabetic blood samples remained the same whether estimations were done immediately or 2 to 3 hours after collection. This eliminated the possibility that the dehydroascorbic acid estimated in diabetic blood was formed by spontaneous oxidation of ascorbic acid to dehydroascorbic acid during the 1 to 2 hours' delay in analysis.
The estimation of ascorbic acid in plasma was made by titration of the metaphosphoric acid extract of plasma with a standard solution of 2,6dichlorophenol-indophenol (equivalent to 1-21lg ascorbic acid/0·2-Q·4 ml dye). The metaphosphoric Banerjee acid extract was prepared by adding 1 ml of 10% metaphosphoric acid solution to 1 ml plasma and centrifuging. Dehydroascorbic acid was estimated by substracting ascorbic acid from total ascorbic acid in plasma. Total ascorbic acid was estimated in the metaphosphoric acid extract of plasma by the 2,4-dinitrophenyl hydrazine method of Bessey et al. u Spontaneous oxidation of ascorbic acid to dehydroascorbic acid did not take place in normal or diabetic plasma." Full recovery of added ascorbic acid and dehydroascorbic acid 00-20 Ilg/ml) was obtained from normal and diabetic plasma by this method.
Erythrocytes were separated by centrifuging the heparinised blood, and the red cells were washed with 5 volumes of isotonic saline. Estimations of ascorbic acid and dehydroascorbic acid were done by the method described for whole blood.
Blood glucose was estimated by the glucose oxidase-peroxidase method of Bergrneyer and Bernt-? with slight modifications as described previously. 8
Results

ASCORBIC ACID AND DEHYDROASCORBIC ACID LEVELS
IN BLOOD
Normal and diabetic subjects
Dehydroascorbic acid was practically absent in the blood of normal male and female subjects with no family history of diabetes (Table 1) ; the blood of such subjects contained only ascorbic acid. The mean ascorbic acid and dehydroascorbic acid levels in blood from 119 male and female diabetic patients ( Table 1 ) showed that the dehydroascorbic acid level was remarkably high in maturity-onset diabetes irrespective of age and sex, while the ascorbic acid content was significantly lower than that of normal subjects (P<O·OOI). In the case of 33 patients, blood ascorbic acid levels were not detectable; all the ascorbic acid in the blood was in the form of dehydroascorbic acid. 
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Details of the subjects are given in the 'Patients and Methods' section. Ascorbic acid and dehydroascorbic acid values in diabetic patients were significantly lower (p<O·OOIl and higher (P<O·OOI), respectively, than the corresponding values in normal subjects.
Diabetic patients with a family history ofdiabetes
The data presented in Table 2 pertain to 102maturityonset male and female diabetic patients with a family history of diabetes grouped on the basis of the duration of disease, including 13 newly diagnosed diabetics. In the case of 73 patients the family history of diabetes was not known, whereas 29 patients had a definite family history as indicated in Table 2 . Except for the 13 newly diagnosed cases, the other patients were under treatment with insulin or oral antidiabetic drugs, such as tolbutamide, chloropropamide, or phenformin. In all the cases, "2-b post prandial blood glucose levels were within normal range, 2 ·18 5·0mmol/l. irrespective of age, duration of the disease, family history or treatment, the blood contained a very high level of dehydroascorbic acid. On the other hand, the ascorbic acid level in the blood of these patients was much lower than in normal subjects.
Non-diabetic offspring of diabetic parents
Non-diabetic offspring, numbering 35, of diabetic parents from 12 different families were examined for blood ascorbic acid and dehydroascorbic acid content (Table 3 ). The 2-hour postprandial blood glucose levels of these offspring were within the normal range (2· 8-5·0 mmol/l). It was observed that 90 % of subjects with both parents diabetic (families I to IV) and 24 % of subjects with one parent diabetic (families V to XII) had high blood dehydroascorbic acid concentrations.
Banerjee
Non-diabetic siblings of diabetic patients
The blood samples from non-diabetic siblings (2-hour postprandial blood glucose levels 2·8-5·0 nunol/l) of diabetic patients were collected, and ascorbic acid and dehydroascorbic acid contents were estimated (Table 4 ). It was observed that 75% of the siblings had remarkably high dehydroascorbic acid concentrations in the blood, while the corresponding ascorbic acid values were considerably decreased.
Juvenile diabetic patients
In juvenile diabetic patients, where the duration of diabetes was between one and six years, the blood dehydroascorbic acid levels were markedly elevated. In normal subjects of similar age group, the blood dehydroascorbic acid content was negligible (Table 5 ). • 2-h post-prandial blood B1ucoselevels of siblings were within normal range, 2·78-5·0 mmol/l. Duration of diabetes detected was between I and 6 years. Ascorbic acid and dehydroascorbic acid values in diabetic patients were significantly lower (p<O·ool) and higher (P<O·ool), respectively, than the corresponding values in normal subjeets. :l: 1·14 :l: 6·25
Concentrations in plasma and erythrocytes represent the concentration in these fractions from I litre of whole blood.
DISTRIBUTION OF ASCORBIC ACID AND DEHYDRO-ASCORBIC ACID IN THE BLOOD
Normal subjects and diabetic patients
The distribution of blood ascorbic acid and dehydroascorbic acid between plasma and erythrocytes of normal subjects and diabetic patients is presented in Table 6 . The table indicates that in the blood of diabetic patients about 75 % of blood dehyroascorbic acid was accumulated in the erythrocytes and the rest was in plasma. It was observed that leucocytes did not contain any dehydroascorbic acid.
Discussion
The results presented in this communication indicate that blood of diabetic patients, irrespective of age, sex, and duration of the disease and family history, contain a remarkably high level of dehydroascorbic acid. On the other hand, dehydroascorbic acid is practically absent in the blood of normal subjects. Dehydroascorbic acid levels were also high in the blood of juvenile diabetics, while it was absent in normal subjects of the same age. It was reported earlier" that in diabetic subjects the blood dehydroascorbic acid levels remained persistently high when examined at four-monthly intervals for one year. The data given in Table 2 indicate that blood dehydroascorbic acid levels were high in newly diagnosed, untreated diabetics as well as in those suffering for 10 to 26 years and receiving treatment with insulin or oral antidiabetic drugs. These results indicate that high blood dehydroascorbic acid content is independent of treatment with antidiabetic agents. Chatterjee et al." postulated that a cause of diabetes mellitus may be a metabolic defect leading to accumulation of dehydroascorbic acid in the blood. The data presented, therefore, indicate that treatment with insulin or antidiabetic drugs does not correct the metabolic defect although it is well known that such treatment temporarily lowers the blood glucose levels. Table 6 shows that 75 % of blood dehydroascorbic acid in diabetic patients was located in the erythrocytes. It has been reported that the uptake of ascorbic acid in erythrocytes takes place in the form of dehydroascorbic acid.P However, in normal blood, dehydroascorbic acid does not accumulate. This is possibly because dehydroascorbic acid is reduced back to ascorbic acid in the erythrocytes. I2-14 The reduction of dehydroascorbic acid in erythrocytes is dependent on the presence of reduced glutathione at appropriate concentration and the activities of glutathione reductase (EC 1.6.4.2) and glucose-6-phosphate dehydrogenase (EC 1.1.1.49).14 The level of reduced glutathione in erythrocytes is regulated by NADPH-dependent glutathione reductase, while the NADPH availability is controlled by the activity of glucose-6-phosphate dehydrogenase. 14 15 The presence of such sequential reactions leading to the reduction of dehydroascorbic acid in erythrocytes of normal blood has been shown by Basu et al. 14 In diabetes, the accumulation of dehydroascorbic acid in erythrocytes may possibly be due to an impairment of the above sequential reactions. However, the present study revealed that the level of reduced glutathione and the activity of glucose-6-phosphate dehydrogenase in erythrocytes of diabetic patients were not different from those of the normal subjects. Similar observations have also been recorded by others,1617 although contradictory reports have been made elsewhere in the literature." 20 This suggests that, apart from the glutathione systems and glucose-6-phosphate dehydrogenase activity, some other factors may possibly playa part in the accumulation of dehydroascorbic acid in the red cells of diabetics, the exact nature of which necessitates further investigation.
In recent years attempts have been made to discover some abnormality or marker for the early detection of diabetes. [21] [22] [23] [24] [25] The results presented in Table 3 show that blood dehydroascorbic acid levels were markedly increased in 90 % of the non-diabetic offspring of two diabetic parents and in 24 % of the non-diabetic offspring of one diabetic parent. This is similar to the statistical observation that 94 % of the offspring with both parents diabetic become overtly diabetic in later life,26 and 20% of the offspring with one diabetic parent become diabetic sometime in their life. 272s Blood dehydroascorbic acid levels were also high in 75% of the non-diabetic siblings of diabetic parents (Table 4 ). These observations indicate that blood dehydroascorbic acid content is high not only in diabetic patients but also in persons with a hereditary predisposition to diabetes.
Dehydroascorbic acid has been reported to be diabetogenic. 1 2 Administration of dehydroascorbic acid to rats resulted in degranulation of the f3-cIIls of the islets of Langerhans accompanied by hyperglycaemia." 4 However, the mechanism of action of dehydroascorbic acid as a diabetogenic agent is not clear. Dehydroascorbic acid is known to react readily with reduced glutathione and other sulphydryl compounds. 29 It has been reported that injection of reduced glutathione or cysteine before injection of dehydroascorbic acid in rats prevents the development of diabetes.P Pillsbury et al.SI indicated that dehydroascorbic acid may exert its diabetogenic effect by combining with cell membrane sulphydryl groups essential for islet cell integrity. Dehydroascorbic acid may, therefore, be associated with the development of diabetes, and persons with a hereditary predisposition to diabetes and with high blood dehydroascorbic acid concentrations may become overtly diabetic at some time during their life. In other words, blood dehydroascorbic acid level may be used as a marker for the early detection of diabetes in persons with a hereditary predisposition.
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